MENU
AVBP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ArriVent BioPharma (AVBP) Ownership - Who owns ArriVent BioPharma?
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more
Profile
Industry
N/A
Address
18 Campus Boulevard
Phone
+1 628 277-4836
Employees
40
Web
https://arrivent.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
796.13M
P/E Ratio
N/A
Total Cash
176.08M
Projected Growth
N/A
Total Debt
138K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.15
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AVBP
Capitalization
796M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
176M
Total Cash/Share
5.15
Total Debt
138K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
203M
P/B Ratio
3.93
Cash Flow
N/A
Earnings
-3.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
14.34
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-140.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.92
Shares Held By Institutions
663M
Shares Outstanding - Current
34.2M
Total Liabilities
13M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-11.299
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18 Campus Boulevard
Phone
+1 628 277-4836
Employees
40
Web
https://arrivent.com